Teradyne (NASDAQ:TER) Releases Quarterly Earnings Results, Beats Estimates By $0.45 EPS

Key Points

• Teradyne reported a strong quarter, with EPS $2.56 versus analyst estimates of $2.11 and revenue up 87% year‑over‑year, driven by robust Semiconductor Test, Robotics and Product Test results.
• The company gave mixed Q2 guidance—EPS $1.860–$2.150 and revenue ~$1.2B–$1.3B—with the lower end of the EPS range below consensus, a development that helped spark an intraday sell‑off (stock down $21.87).
• Wall Street sentiment remains positive overall (consensus "Moderate Buy" with several price‑target increases), but the shares trade at a rich valuation (P/E ~109) and have shown large volatility within a wide 52‑week range.

Teradyne (NASDAQ:TER - Get Free Report) released its earnings results on Tuesday. The company reported $2.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.11 by $0.45, Zacks reports. Teradyne had a return on equity of 22.68% and a net margin of 17.37%.During the same period in the prior year, the company earned $0.75 EPS. The company's revenue for the quarter was up 87.0% compared to the same quarter last year. Teradyne updated its Q2 2026 guidance to 1.860-2.150 EPS.

Teradyne Price Performance

NASDAQ TER traded down $21.87 during trading on Tuesday, reaching $380.13. 4,547,903 shares of the company's stock were exchanged, compared to its average volume of 3,338,028. The business has a 50 day moving average price of $327.21 and a 200-day moving average price of $246.20. The stock has a market capitalization of $59.51 billion, a P/E ratio of 109.23, a PEG ratio of 2.46 and a beta of 1.79. Teradyne has a fifty-two week low of $71.27 and a fifty-two week high of $422.11.

Key Headlines Impacting Teradyne

Here are the key news stories impacting Teradyne this week:

• Positive Sentiment: Teradyne reported strong Q1 results: revenue $1,282M (up vs prior year) with GAAP EPS $2.53 and non‑GAAP EPS $2.56; GAAP net income was $398.9M and segment detail showed Semiconductor Test $1,111M, Robotics $91M, Product Test $80M — this demonstrates healthy demand in core test products. Teradyne Reports First Quarter 2026 Results
• Positive Sentiment: Analyst sentiment: Stifel raised its price target to $390 and maintained a Buy, signaling continued analyst confidence in Teradyne’s growth trajectory. Benzinga
• Positive Sentiment: Partnership and thematic support: Teradyne expanded its robotics partnership with Flex to accelerate intelligent automation, and it was listed among robotics-themed stocks to watch — both items support the company’s longer‑term robotics/recurrent‑revenue thesis. Flex And Teradyne Robotics Expand Partnership | Zacks robotics list
• Neutral Sentiment: Corporate disclosures and filing notes: the company’s earnings release and accompanying investor materials (slides/transcript) are available — helpful for modeling but expected after the print. Press Release / Investor Materials
• Neutral Sentiment: Media previews/transcripts: several earnings previews and the call transcript were posted ahead/after the print — useful for color but not new fundamental information. Earnings Call Transcript | Earnings preview
• Negative Sentiment: Q2 guidance came in mixed-to-conservative: Teradyne set Q2 EPS guidance at $1.860–$2.150 vs. consensus ~$1.92 (the low end is below consensus), and revenue guidance of $1.2B–$1.3B roughly in line with expectations. The slightly softer EPS guide appears to have triggered the intra‑day selling despite the strong quarter. (Note: an apparent earnings‑metadata typo listing EPS as $999 in some feeds is erroneous — use the company press release figures above.)

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TER. Caitong International Asset Management Co. Ltd bought a new stake in Teradyne in the 4th quarter valued at $28,000. DV Equities LLC bought a new position in Teradyne during the fourth quarter worth $42,000. Vestor Capital LLC bought a new position in Teradyne during the fourth quarter worth $48,000. Intesa Sanpaolo Wealth Management acquired a new position in shares of Teradyne in the fourth quarter valued at $48,000. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Teradyne in the second quarter valued at $35,000. 99.77% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

TER has been the subject of several recent research reports. Weiss Ratings reissued a "hold (c)" rating on shares of Teradyne in a research report on Tuesday, April 21st. JPMorgan Chase & Co. upped their price objective on Teradyne from $315.00 to $400.00 and gave the stock a "neutral" rating in a research note on Thursday, April 16th. Northland Securities reissued a "market perform" rating and issued a $270.00 price objective on shares of Teradyne in a report on Wednesday, February 4th. TD Cowen reissued a "buy" rating on shares of Teradyne in a research note on Thursday, January 22nd. Finally, Evercore restated an "outperform" rating and set a $430.00 target price on shares of Teradyne in a report on Monday. Ten equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $328.87.

About Teradyne

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company's product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.